Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The New Developed FIVE Score and Its Comparison With GCS and FOUR Scores Regarding Length of Hospital Stay Morbidity and Mortality in Neuro-intensive Care Patients. an Observational Prospective Study

NCT06036732 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

NCT NCT06036732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06036732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The New Developed FIVE Score and Its Comparison With GCS and FOUR Scores Regarding Length of Hospital Stay Morbidity and Mortality in Neuro-intensive Care Patients. an Observational Prospective Study
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
February 25, 2024
Enrollment
223 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arnold chiari malformation, assessment, self, cerebrovascular event, coma, epilepsy, temporal lobe, infratentorial neoplasms, intensive care neurological disorder, postoperative intracranial haemorrhage, postoperative intracranial hematoma, subarachnoid hemorrhage, supratentorial cancer, traumatic brain injury, unconsciousness